Global Biosimilar Monoclonal Antibodies Market to Touch US$ 25770 MILLION by 2026; Growing at 27.7% CAGR during 2021-2026 The global Biosimilar Monoclonal Antibodies market was valued at US$ 4574.3 million in 2019 and is expected to reach US$ 25770 million by the end of 2026, growing at a CAGR of 27.7% during 2021-2026. Monoclonal antibodies […]
